Cargando…

How COVID-19 affects patients receiving anticytokine and JAK inhibitors in rheumatology and dermatology

Detalles Bibliográficos
Autores principales:	Jessica Chang, Ting Yi, Pope, Janet E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346716/ https://www.ncbi.nlm.nih.gov/pubmed/32640861 http://dx.doi.org/10.2217/imt-2020-0153

Ejemplares similares

Viral Anticytokine Strategies
por: Alcami, Antonio
Publicado: (2016)

Update on Anticytokine Treatment for Asthma
por: Gallelli, Luca, et al.
Publicado: (2013)

Anticytokine Autoantibodies and Fungal Infections
por: Kappagoda, Shanthi, et al.
Publicado: (2023)

Preventing COVID-19-induced pneumonia with anticytokine therapy
por: Monteleone, Giovanni, et al.
Publicado: (2020)

JAK Inhibitors in Rheumatology: Implications for Paediatric Syndromes?
por: Kerrigan, S. A., et al.
Publicado: (2018)

Anticytokine Autoantibodies: Association with Infection and Immune Dysregulation
por: Knight, Vijaya, et al.
Publicado: (2016)

JAK-STAT pathway inhibitors in dermatology()
por: Miot, Hélio Amante, et al.
Publicado: (2023)

How Twitter use in Rheumatology has Evolved
por: Lim, Irwin
Publicado: (2022)

Anticytokine therapy for periodontal diseases: Where are we now?
por: Waykole, Yogesh Prakash, et al.
Publicado: (2009)

Profiling Serum Cytokines and Anticytokine Antibodies in Psoriasis Patients
por: Hong, Dan, et al.
Publicado: (2022)

Under Development JAK Inhibitors for Dermatologic Diseases
por: Sideris, Nikolaos, et al.
Publicado: (2020)

Emerging Topical and Systemic JAK Inhibitors in Dermatology
por: Solimani, Farzan, et al.
Publicado: (2019)

Therapeutic targeting of JAKs: from hematology to rheumatology and from the first to the second generation of JAK inhibitors
por: Bertsias, George
Publicado: (2020)

Are we there yet? An update on transitional care in rheumatology
por: McDonagh, Janet E., et al.
Publicado: (2018)

Rheumatology Care in the Face of COVID-19
por: Lubrano, Ennio, et al.
Publicado: (2020)

Anticytokine autoantibodies leading to infection: early recognition, diagnosis and treatment options
por: Barcenas-Morales, Gabriela, et al.
Publicado: (2019)

A genome-engineered bioartificial implant for autoregulated anticytokine drug delivery
por: Choi, Yun-Rak, et al.
Publicado: (2021)

Comparison of Anakinra and Tocilizumab in Anticytokine Therapy in the Treatment of Coronavirus Disease-2019
por: Ozkan, Feyza, et al.
Publicado: (2022)

Rheumatology in East Asia
por: Yamamoto, Kazuhiko, et al.
Publicado: (2018)

The Your Rheum story: involvement of young people in rheumatology research
por: Esen, Ecem, et al.
Publicado: (2022)

Risk/benefit trade-offs in rheumatology: rofecoxib revisited in the era of JAK inhibitors
por: Hazlewood, Glen S
Publicado: (2023)

A Comment on JAK Inhibitors for Treatment of Alopecia Areata
por: Trüeb, Ralph Michel, et al.
Publicado: (2018)

What Does the COVID-19 Pandemic Mean for Rheumatology Patients?
por: Pope, Janet E.
Publicado: (2020)

How the COVID-19 pandemic has affected rheumatology research
por: Moreyra, Paula Alba, et al.
Publicado: (2022)

Rheumatology in Africa—challenges and opportunities
por: Mody, Girish M.
Publicado: (2017)

Rheumatology in Greece: pros and cons
por: Moutsopoulos, Haralampos M.
Publicado: (2020)

Virtual Rheumatology During COVID-19: A Personal Perspective
por: Dacre, Jane
Publicado: (2020)

Dealing with COVID-19 in a Pediatric Rheumatology Unit in Italy
por: Costi, Stefania, et al.
Publicado: (2020)

Suppress for Success: A JAK Inhibitor for Adjunct Therapy of Tuberculosis
por: Dorhoi, Anca
Publicado: (2015)

Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
por: Blume-Peytavi, Ulrike, et al.
Publicado: (2015)

A new player in psoriatic arthritis: a JAK inhibitor
por: Sakkas, Lazaros I.
Publicado: (2017)

Social media dermatologic advice: Dermatology without dermatologists
por: Trepanowski, Nicole, et al.
Publicado: (2023)

Latin-American challenges and opportunities in rheumatology
por: Rocha, Francisco Airton Castro
Publicado: (2017)

Fumarates in dermatology
por: Rajagopalan, Murlidhar
Publicado: (2011)

Cutaneous cryptococcosis in a patient with myelofibrosis receiving JAK‐inhibitor
por: Chen, Jui‐Che, et al.
Publicado: (2021)

ROCKing the JAKs
por: Peelman, Frank, et al.
Publicado: (2013)

Glitches in the utilization of telehealth in pediatric rheumatology patients during the COVID-19 pandemic
por: Balmuri, Nayimisha, et al.
Publicado: (2020)

A Review on the Safety of Using JAK Inhibitors in Dermatology: Clinical and Laboratory Monitoring
por: Samuel, Christeen, et al.
Publicado: (2023)

A peripatetic pediatrician's journey into pediatric rheumatology
por: Brewer, Earl J
Publicado: (2007)

Opportunities and challenges in rheumatology research in Central Europe
por: Szekanecz, Zoltán, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_g5mio8qtip6pn0adrrmd4lts40